Achieving sufficient delivery across the blood–brain barrier is a key challenge in the
development of drugs to treat central nervous system (CNS) disorders. This is particularly …

Solid lipid nanoparticle (SLN), nanostructured lipid carriers (NLC) and hybrid nanoparticles,
have gained increasing interest as drug delivery systems because of their potential to load …

Essential oils are odorant liquid oily products consisting of a complex mixture of volatile
compounds obtained from a plant raw material. They have been increasingly proven to act …

This review focuses on key topics in the field of drug delivery related to the design of
nanocarriers answering the biomedicine criteria, including biocompatibility, biodegradability …

New mixed cationic liposomes based on L-α-phosphatidylcholine and
dihexadecylmethylhydroxyethylammonium bromide (DHDHAB) were designed to overcome …

Methyl paraoxon (MOX) is a highly toxic organophosphate pesticide. It is recently reported
that, MOX can enter the human body through ingestion, inhalation, or by dermal penetration …

Obviously, delivery of the medications to the brain is more difficult than other tissues due to
the existence of a strong obstacle, which is called blood-brain barrier (BBB). Because of the …

Primary brain and central nervous system (CNS) tumors are a diverse group of neoplasms
that occur within the brain and spinal cord. Although significant advances in our …

Advancements in both material science and bionanotechnology are transforming the health
care sector. To this end, nanoparticles are increasingly used to improve diagnosis …

Organophosphorus agents (OP) are widely used as pesticides due to their cost
effectiveness, yet they present a significant public health risk owing to their high toxicity …